National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 354607

(NOTE: This result is from the 9/14/2017 version of the VAERS database)

Case Details

VAERS ID: 354607 (history)  
Form: Version 1.0  
Age: 0.21  
Gender: Female  
Location: New York  
Vaccinated:2009-07-08
Onset:2009-07-15
   Days after vaccination:7
Submitted: 2009-08-05
   Days after onset:21
Entered: 2009-08-07
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C3084AA / UNK UN / UN
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR B0476 / UNK UN / UN
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH D4687U / UNK UN / UN
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41OA733A / 1 MO / PO

Administered by: Private       Purchased by: Private
Symptoms: Dehydration, Intussusception, Vomiting
SMQs:, Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Gastrointestinal obstruction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: There were no reported concomitant medications or relevant medical history. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK. 10/2/09 Hospital records, DC summary, received DOS 7/16/09 to 7/17/09. LABS and DIAGNOSTICS: Ultrasound Abdomen Abnormal. CBC - WBC 14.6 (H) HCT 30.2% (L) MCV 91.1 (L) MCH 31.5 MMG (L) Platelets 454 THO/UL (H) Mono 16% (H) Atyp Lymph 2% (H). CHEM - CL 110 MEQ/L (H) Protein 5.5 GM/DL (L).
CDC Split Type: A0799191A

Write-up: This case was reported by a healthcare professional and described the occurrence of intussusception in a 2-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). There were no reported concomitant medications or relevant medical history. The subject had not experienced adverse events following previous vaccinations. Concurrent vaccination included DAPTACEL (non-gsk) (Sanofi) given on 8 July 2009; PREVNAR (non-gsk) (Wyeth Labs) given on 8 July 2009; IPOL (non-gsk) (Sanofi) given on 8 July 2009. On 8 July 2009 the subject received 1st dose of ROTARIX (1 ml; oral). The lot number was reported as A41OA733A. On 15 July 2009, 7 days after vaccination with ROTARIX, the subject experienced intussusception and "severe" vomiting. The subject was hospitalised and the healthcare professional considered the events were clinically significant (or requiring intervention). At the time of reporting the events were improved. The healthcare professional considered the events were probably related to vaccination with ROTARIX. 10/2/09 Hospital records, DC summary, received DOS 7/16/09 to 7/17/09. Assessment: Intussusception. Presented to ER with 2 days of increased vomiting, fussiness, and decreased stooling, no wet diapers. Fever, respirations and heart rate elevated. Rash below chin. Abdomen rigid. Symptoms resolved with air enema. Some ascites. ICD-9 Codes: 560.0 Intussusception, 276.51 Dehydration. Follow-up information received on 21 August 2009 indicated that the events began on 15 July 2009 and resolving by the following day, 16 July 2009. The subject received an enema for treatment and symptoms resolved. In the reporter''s opinion, the events were probably related to treatment with ROTARIX. The child did not receive bowel resection.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?SNAPSHOT=20170914&IDNUMBER=354607


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166